Company Formycon AG

Equities

FYB

DE000A1EWVY8

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 16:35:20 11/02/2026 GMT			Pre-market 06:16:01
23.95 ^EUR	+1.91%		23.85	-0.42%

02-11	Formycon, Lotus Sign License Deal for Keytruda Biosimilar in Asia-Pacific Region	MT
02-11	Swiss stocks - Factors to watch on February 11	RE

Business description: Formycon AG

Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.

Number of employees: 250

Sales by Activity: Formycon AG

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Biotechnology	34.23M	36.96M	42.5M	77.7M	69.67M

See all business segments

Geographical breakdown of sales: Formycon AG

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Switzerland	-	-	10.45M	52.24M	52.08M
Germany	34.23M	36.96M	32.04M	25.46M	17.59M

See all geographic segments

Executive Committee: Formycon AG

Manager	Title	Age	Since
Stefan Glombitza CEO	Chief Executive Officer	-	30/06/2022
Enno Spillner DFI	Director of Finance/CFO	57	31/03/2023
Andreas Seidl CTO	Chief Tech/Sci/R&D Officer	-	30/06/2022
Sabrina Müller IRC	Investor Relations Contact	-	-
Nicola Mikulcik Ohrner PRN	Corporate Officer/Principal	55	31/05/2022

See FORMYCON AG governance

Composition of the Board of Directors: Formycon AG

Director	Title	Age	Since
Klaus Röhrig BRD	Director/Board Member	49	09/12/2020
Wolfgang Essler CHM	Chairman	54	11/06/2024
Bodo Coldewey BRD	Director/Board Member	54	11/06/2024
Nicholas Haggar BRD	Director/Board Member	60	11/06/2024
Colin Michael Bond BRD	Director/Board Member	66	30/09/2024
Graham Dixon BRD	Director/Board Member	65	17/06/2025

Composition of the Board of Directors

Shareholders: Formycon AG

Name	Equities	%	Valuation
Struengmann Family 24.03 %	4,246,528	24.03 %	116 M €
Wendeln & Cie. KG 13.24 %	2,340,537	13.24 %	64 M €
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Rt. 9.075 %	1,603,877	9.075 %	44 M €
Active Ownership Corp SARL 6.037 %	1,066,931	6.037 %	29 M €
Detlef Spruth 5.094 %	900,206	5.094 %	25 M €

List of FORMYCON AG shareholders

Company details: Formycon AG

Formycon AG

Fraunhoferstraße 15

82152, Munich

+49 89 864 667 100

http://formycon.com

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
FORMYCON AG	+1.91%	+3.90%	-54.03%	-69.87%	502M
LONZA GROUP AG	-1.90%	-3.65%	-16.75%	-6.74%	46.14B
BEONE MEDICINES AG	-0.61%	-0.21%	+58.79%	+43.68%	38.87B
CELLTRION, INC.	+5.27%	+11.66%	+38.61%	+61.04%	36.18B
IQVIA HOLDINGS INC.	-2.89%	-12.52%	-11.80%	-20.49%	30.05B
REVOLUTION MEDICINES, INC.	+2.09%	+1.53%	+136.41%	+298.66%	18.94B
EUROFINS SCIENTIFIC SE	-4.06%	-4.63%	+27.61%	-4.12%	13.55B
ASCENDIS PHARMA A/S	-1.20%	+0.80%	+85.33%	+94.37%	13.6B
IONIS PHARMACEUTICALS, INC.	+0.07%	-0.75%	+167.10%	+116.28%	13.66B
REGENCELL BIOSCIENCE HOLDINGS LIMITED	+0.15%	-5.85%	+27,082.10%	+3,523.54%	13.21B
Average	-0.35%	-1.13%	+2,751.34%	+403.64%	22.47B
Weighted average by Cap.	-0.16%	-1.32%	+1,632.15%	+258.00%